Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zili An
AGS67E, an Anti-Cd37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Analysis of Preclinical and Clinical Samples After Treatment With a CD37 Targeting Antibody Drug Conjugate (AGS67E) Support a High Level of CD37 Expression in NHL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Regulatory Role for CD37 in T Cell Proliferation
Journal of Immunology
Allergy
Immunology
Efficacy of an Anti-Cd22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B-Cell Acute Lymphoblastic Leukemia
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Targeting B-Cell Malignancies With the Beta-Emitting Anti-Cd37 Radioimmunoconjugate 177Lu-Nnv003
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates
Separations
Filtration
Analytical Chemistry
Separation
A Complementary Role for the Tetraspanins CD37 and Tssc6 in Cellular Immunity
Journal of Immunology
Allergy
Immunology
miR-133 Regulates Evi1 Expression in AML Cells as a Potential Therapeutic Target
Scientific Reports
Multidisciplinary
The Making of a Leukemic Stem Cell: A Novel Role for IKZF2 in AML Stemness and Differentiation
Cell Stem Cell
Molecular Medicine
Genetics
Cell Biology
Preliminary Results of a Phase 1 Dose Escalation Study of the First-In-Class Anti-Cd74 Antibody Drug Conjugate (Adc), Stro-001, in Advanced B-Cell Malignancies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
